<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02661243</url>
  </required_header>
  <id_info>
    <org_study_id>NL47808.029.14</org_study_id>
    <nct_id>NCT02661243</nct_id>
  </id_info>
  <brief_title>Implantology and Sjögren's Syndrome</brief_title>
  <official_title>Implantology and Sjögren's Syndrome: a Multicenter Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Derk Jan Jager</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tandartspraktijk Bocht Oosterdiep</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Isala</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>BioHorizons, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fonds NutsOhra</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VU University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Until now it has not been investigated whether placement of implants in SS patients is less&#xD;
      successful than compared to non-SS patients. The risk factors and the efficacy of dental&#xD;
      implants in dry mouth patients are not known because of the lack of scientific evidence. The&#xD;
      aim of this study is to investigate changes in marginal peri-implant bone loss and the&#xD;
      clinical performance of dental implants in SS patients compared to implants in healthy&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: Until now it has not been investigated whether placement of implants in SS&#xD;
      patients is less successful than compared to non-SS patients. The risk factors and the&#xD;
      efficacy of dental implants in dry mouth patients are not known because of the lack of&#xD;
      scientific evidence.&#xD;
&#xD;
      Objective: to investigate changes in marginal peri-implant bone loss and the clinical&#xD;
      performance of dental implants in SS patients compared to implants in healthy patients.&#xD;
&#xD;
      Study design: A prospective multicenter clinical trial.&#xD;
&#xD;
      Study population: N = 120&#xD;
&#xD;
      Intervention: All patients receive Biohorizons Laser-lok bonelevel implants to replace the&#xD;
      missing (pre)molars or to support a full denture in the upper and lower jaw .&#xD;
&#xD;
      This study is comprised of four study groups:&#xD;
&#xD;
        -  30 human adults affected by SS with the need of replacement of missing premolars or&#xD;
           molars in the upper or lower jaw.&#xD;
&#xD;
        -  30 healthy human adults with the need of replacement of missing premolars or molars in&#xD;
           the upper or lower jaw.&#xD;
&#xD;
        -  30 human edentulous adults affected by SS with the need of stabilization of the&#xD;
           dentures.&#xD;
&#xD;
        -  30 healthy human edentulous adults with the need of stabilization of the dentures.&#xD;
&#xD;
      Main study parameters/endpoints: changes in marginal peri-implant bone loss of dental&#xD;
      implants between the healthy and SS groups and differences in clinical performance 1.5 years&#xD;
      after finalization.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">February 2019</completion_date>
  <primary_completion_date type="Actual">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in marginal peri-implant bone loss of dental implants</measure>
    <time_frame>1.5 years</time_frame>
    <description>changes in marginal peri-implant bone loss of dental implants between the healthy and SS groups and differences in clinical performance 1.5 years after finalization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implant survival</measure>
    <time_frame>1.5 years</time_frame>
    <description>The survival rate of the fixture is assessed 1 month, 6 months, 1 year and 1.5 years after placement of the definitive restoration. Implant survival is defined as presence of the implant at time of the follow-up examinations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overdenture/crown survival</measure>
    <time_frame>1.5 years</time_frame>
    <description>The survival (i.e. fully intact) rate of the denture or crown is assessed 1 month, 6 months, 1 year and 1.5 years after placement of the definitive restoration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Plaque-index and Modified Bleeding-Index</measure>
    <time_frame>1.5 years</time_frame>
    <description>These parameters are evaluated pre-operative, 1 month, 6 months, 1 year and 1.5 years after placement of the definitive restoration. The adjacent teeth are counted as well in the assessments (dentate groups only).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing depth</measure>
    <time_frame>1.5 years</time_frame>
    <description>Probing of the implant and the adjacent teeth (dentate groups only) is performed at three sites, buccodistal, buccomedial, buccomesial. The probing depth is measured 1 month, 6 months, one year and 1.5 years after placement of the definitive restoration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Width of keratinized epithelium</measure>
    <time_frame>1.5 years</time_frame>
    <description>The width in millimetres of keratinized epithelium is measured pre-operative, 1 month, 6 months, 1 year and 1.5 years after the definitive restoration has been placed. For this a periodontal probe is used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction and impact of oral health on the quality of life</measure>
    <time_frame>1.5 years</time_frame>
    <description>- All patients: OHIP-NL14. Oral Health Impact Profile. An instrument for measuring the impact of oral health on the quality of life. A validated Dutch-language version of the OHIP-14, a questionnaire by means of which the impact of oral health on the quality of life of patients can be determined is completed by every participant at every examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Denture function and satisfaction</measure>
    <time_frame>1.5 years</time_frame>
    <description>Edentulous groups: the following validated questionnaires are used for the edentulous groups only (see attachment; Vervoorn et al., 1988):&#xD;
A. General experience with the denture, including a grade from 1 tot 10&#xD;
B. Complaints form with regard to aesthetics and function of the denture&#xD;
C. Chewing list (which food can be chewed well and which food is difficult to chew).&#xD;
The participant at every time point completes these questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease symptoms (SS groups only)</measure>
    <time_frame>1.5 years</time_frame>
    <description>patients in the SS groups are asked to complete the EULAR Sjögren's Syndrome Patient Reported Index and the EULAR Sjögren's Syndrome Disease Activity Index (ESSPRI &amp; ESSDAI; see attachment) questionnaire with regard to disease symptoms</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Sjogren's Syndrome</condition>
  <arm_group>
    <arm_group_label>Dentate Sjogren's syndrome arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30 human adults affected by SS with the need of replacement of missing premolars or molars in the upper or lower jaw. Intervention: insertion of Biohorizons Laser-lok bonelevel dental implants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dentate healthy controls arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30 healthy human adults with the need of replacement of missing premolars or molars in the upper or lower jaw. Intervention: insertion of Biohorizons Laser-lok bonelevel dental implants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Edentulous Sjogren's syndrome arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30 human edentulous adults affected by SS with the need of stabilization of the dentures. Intervention: insertion of Biohorizons Laser-lok bonelevel dental implants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Edentulous healthy controls arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30 healthy human edentulous adults with the need of stabilization of the dentures. Intervention: insertion of Biohorizons Laser-lok bonelevel dental implants</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biohorizons Laser-lok bonelevel dental implants</intervention_name>
    <description>Insertion of Biohorizons Laser-lok bonelevel dental implants to replace missing (pre)molars or to stabilize a denture</description>
    <arm_group_label>Dentate Sjogren's syndrome arm</arm_group_label>
    <arm_group_label>Dentate healthy controls arm</arm_group_label>
    <arm_group_label>Edentulous Sjogren's syndrome arm</arm_group_label>
    <arm_group_label>Edentulous healthy controls arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria (dentate group, Sjögren):&#xD;
&#xD;
          -  The patient is at least 18 years and younger than 70;&#xD;
&#xD;
          -  A diagnosed (by the AECG guidelines; see attachment; Vitali et al., 2002) primary or&#xD;
             secondary Syndrome of Sjögren;&#xD;
&#xD;
          -  The missing or lost tooth/teeth are premolars and/or molars in the upper or lower jaw.&#xD;
&#xD;
          -  Sufficient healthy and vital bone to insert a dental implant with a minimum length of&#xD;
             8 mm and at least 3.8 mm in diameter. In case of insufficient bone volume, a bone&#xD;
             augmentation procedure will be performed with autologue bone. If necessary the&#xD;
             autologue bone can be mixed with artificial bone (artificial bone graft substitutes in&#xD;
             combination with a membrane).&#xD;
&#xD;
          -  The implant site must be free from infection;&#xD;
&#xD;
          -  Adequate oral hygiene (modified plaque index and modified sulcus bleeding index ≤ 1)&#xD;
             (Mombelli et al., 1987; Loe and Silness, 1963)&#xD;
&#xD;
          -  Sufficient mesio-distal, bucco-lingual, and interocclusal space for placement of an&#xD;
             anatomic restoration;&#xD;
&#xD;
          -  The patient is capable of understanding and giving informed consent.&#xD;
&#xD;
        Inclusion criteria (edentulous group, Sjögren):&#xD;
&#xD;
          -  The patient is at least 18 years and younger than 70;&#xD;
&#xD;
          -  A diagnosed (by the AECG guidelines; Vitali et al., 2002) primary or secondary&#xD;
             Syndrome of Sjögren&#xD;
&#xD;
          -  The patient is edentulous. Before final inclusion in the study the patient has to be&#xD;
             edentulous for 1 year.&#xD;
&#xD;
          -  Problems with conventional denture retention, stability and/or adaptation, which could&#xD;
             be solved by an implant, supported denture (lower or/and upper jaw).&#xD;
&#xD;
          -  Sufficient healthy and vital bone to insert dental implants with a minimum length of 8&#xD;
             mm and at least 3.8 mm in diameter. In case of insufficient bone volume, a bone&#xD;
             augmentation procedure will be performed with autologue bone. If necessary the&#xD;
             autologue bone can be mixed with artificial bone (artificial bone graft substitutes in&#xD;
             combination with a membrane).&#xD;
&#xD;
          -  The implant site must be free from infection;&#xD;
&#xD;
          -  Capable of performing adequate oral hygiene;&#xD;
&#xD;
          -  The patient is capable of understanding and giving informed consent.&#xD;
&#xD;
        Inclusion criteria control groups:&#xD;
&#xD;
        - The inclusion criteria for the healthy control groups are similar as for the Sjögren&#xD;
        groups without the Sjögren criterion.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        Criteria used for excluding patients from this study are as follows:&#xD;
&#xD;
          -  Medical and general contraindications for the surgical procedures;&#xD;
&#xD;
          -  Presence of an active and uncontrolled periodontal disease as expressed by probing&#xD;
             pockets depths &gt; 4mm with bleeding upon probing;&#xD;
&#xD;
          -  Smoking (patients who stop smoking six weeks before the operation can be included);&#xD;
&#xD;
          -  A history of radiotherapy to the head and neck region;&#xD;
&#xD;
          -  Use of intravenous bisphosphonates or the use of oral bisphosphonates for more than 5&#xD;
             years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Derk Jan Jager, DMD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VU University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VU Medical Center department of Maxillofacial surgery</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700 RB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3508 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tandartspraktijk Bocht Oosterdiep</name>
      <address>
        <city>Veendam</city>
        <zip>9641 JH</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vogellanden Center for Special Care Dentistry/Isala</name>
      <address>
        <city>Zwolle</city>
        <zip>8001 BB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>den Hartog L, Slater JJ, Vissink A, Meijer HJ, Raghoebar GM. Treatment outcome of immediate, early and conventional single-tooth implants in the aesthetic zone: a systematic review to survival, bone level, soft-tissue, aesthetics and patient satisfaction. J Clin Periodontol. 2008 Dec;35(12):1073-86. doi: 10.1111/j.1600-051X.2008.01330.x. Review.</citation>
    <PMID>19040585</PMID>
  </reference>
  <reference>
    <citation>Pecora GE, Ceccarelli R, Bonelli M, Alexander H, Ricci JL. Clinical evaluation of laser microtexturing for soft tissue and bone attachment to dental implants. Implant Dent. 2009 Feb;18(1):57-66. doi: 10.1097/ID.0b013e31818c5a6d.</citation>
    <PMID>19212238</PMID>
  </reference>
  <reference>
    <citation>Fox RI. Sjögren's syndrome. Lancet. 2005 Jul 23-29;366(9482):321-31. Review.</citation>
    <PMID>16039337</PMID>
  </reference>
  <reference>
    <citation>Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH; European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 Jun;61(6):554-8. Review.</citation>
    <PMID>12006334</PMID>
  </reference>
  <reference>
    <citation>Meijndert L, Meijer HJ, Raghoebar GM, Vissink A. A technique for standardized evaluation of soft and hard peri-implant tissues in partially edentulous patients. J Periodontol. 2004 May;75(5):646-51.</citation>
    <PMID>15212345</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>January 18, 2016</study_first_submitted>
  <study_first_submitted_qc>January 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2016</study_first_posted>
  <last_update_submitted>April 26, 2019</last_update_submitted>
  <last_update_submitted_qc>April 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>VU University Medical Center</investigator_affiliation>
    <investigator_full_name>Derk Jan Jager</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Sjogren's Syndrome</keyword>
  <keyword>Dental Implants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

